Publications by authors named "Steven S Good"

Claim this Profile
B
Bemnifosbuvir and ruzasvir in combination exhibit potent synergistic antiviral activity in vitro while maintaining a favorable nonclinical safety profile in vivo.
Steven S Good, Shouqi Luo, Kai Lin, Alex Vo, Nancy G B Agrawal

Antiviral Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase.
Xiao-Jian Zhou, Steven S Good, Keith Pietropaolo, Qi Huang, Adel Moussa

Expert Opin Investig Drugs· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.
Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, Barbara Selisko, Mikael Feracci, Steven S Good

Nat Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.
Kai Lin, Steven S Good, Justin G Julander, Abbie E Weight, Adel Moussa

PLoS Negl Trop Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with and Activity against Dengue and Other Flaviviruses.
Steven S Good, Ashleigh Shannon, Kai Lin, Adel Moussa, Justin G Julander

Antimicrob Agents Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 and a Promising Oral Antiviral for Treatment of COVID-19.
Steven S Good, Jonna Westover, Kie Hoon Jung, Xiao-Jian Zhou, Adel Moussa

Antimicrob Agents Chemother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Steven S Good, Adel Moussa, Xiao-Jian Zhou, Keith Pietropaolo, Jean-Pierre Sommadossi

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis.
Elina Berliba, Maxim Bogus, Frédéric Vanhoutte, Pieter-Jan Berghmans, Steven S Good

Antimicrob Agents Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposure.
Xin-Ru Pan-Zhou, Benjamin A Mayes, Hassan Rashidzadeh, Rahela Gasparac, Steven Smith, Steven S Good

Eur J Drug Metab Pharmacokinet· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming stability challenges in the quantification of tissue nucleotides: determination of 2'-C-methylguanosine triphosphate concentration in mouse liver.
Hassan Rashidzadeh, Sanjeev Bhadresa, Steven Spencer Good, Marita Larsson Cohen, Kusum Sachdev Gupta

Biol Pharm Bull· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of human drug clearance using multiexponential techniques.
Kosalaram Goteti, Patrick J Brassil, Steven S Good, C Edwin Garner

J Clin Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Karen K Biron, Robert J Harvey, Stanley C Chamberlain, Steven S Good, Albert A Smith

Antimicrob Agents Chemother· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication.
George W Koszalka, Nelson W Johnson, Steven S Good, Leslie Boyd, Stanley C Chamberlain

Antimicrob Agents Chemother· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis